← Leaderboards
Gautam Dantas
Washington University
$16,547,812
Attributed
$28,586,105
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,198,358 · 10
AHRQ$2,423,873 · 1
CDC$1,963,874 · 1
By mechanism
R01$20,094,528 · 8
U01$6,137,360 · 2
DP2$2,120,967 · 1
R21$233,250 · 1
Top collaborators
- Timothy Adam Wencewicz10 shared
- Carey-Ann Dawn Burnham5 shared
- Jennie H Kwon5 shared
- Tae Seok Moon5 shared
- Thaddeus S Stappenbeck5 shared
- Phillip I Tarr5 shared
- Sanjay K Shukla4 shared
- Erik R Dubberke3 shared
Most similar at Washington University
Same institution · by research overlap
- Avraham Beigelman$2,521,583
- Tae Seok Moon$1,171,356
- Thaddeus S Stappenbeck$13,810,421
- Timothy Adam Wencewicz$3,030,574
- Erik R Dubberke$2,686,761
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationBacteriaAntibioticsMetagenomicsMouse ModelStructureMotivationPublic HealthPathogenMicrobialMicrobiotaGenesDesignClinically RelevantLifeBaseMicrobeCommunitiesMicrobiomeGut MicrobiotaInfantAntibiotic ResistanceFecesCohort
Grant awards (44)
Functional characterization of viral-bacterial-human interactions during antimicrobial and inflammatory perturbations across different lifespans$1,040,503
U01 · FY2025 · AT · contact PI
Impact of early-life perturbations on pediatric microbiome maturation$759,369
R01 · FY2025 · AI · contact PI
High-resolution genomic interrogation of pathogen-microbiome interactions in Clostridioides difficile infection$745,133
R01 · FY2025 · AI · contact PI
Structural, mechanistic, & evolutionary characterization of tetracycline destructases$672,172
U01 · FY2025 · AI · contact PI
Culturomic and metagenomic methods optimization to detect multi-strain C. difficile colonization and infection$233,250
R21 · FY2025 · AI
Functional characterization of viral-bacterial-human interactions during antimicrobial and inflammatory perturbations across different lifespans$1,035,406
U01 · FY2024 · AT · contact PI
Impact of early-life perturbations on pediatric microbiome maturation$769,606
R01 · FY2024 · AI · contact PI
High-resolution genomic interrogation of pathogen-microbiome interactions in Clostridioides difficile infection$746,205
R01 · FY2024 · AI · contact PI
Structural, mechanistic, & evolutionary characterization of tetracycline destructases$681,709
U01 · FY2024 · AI · contact PI
Environmental hygiene strategies to decrease the burden of antibiotic-resistant organisms in Intensive Care Unit SINKs (ICU SINK)$474,732
R01 · FY2024 · HS
Impact of early-life perturbations on pediatric microbiome maturation$776,694
R01 · FY2023 · AI · contact PI
Structural, mechanistic, & evolutionary characterization of tetracycline destructases$692,841
U01 · FY2023 · AI · contact PI
Environmental hygiene strategies to decrease the burden of antibiotic-resistant organisms in Intensive Care Unit SINKs (ICU SINK)$481,910
R01 · FY2023 · HS
Impact of early-life perturbations on pediatric microbiome maturation$753,774
R01 · FY2022 · AI · contact PI
Structural, mechanistic, & evolutionary characterization of tetracycline destructases$709,070
U01 · FY2022 · AI · contact PI
Tunable therapeutic modulation of the gut microbiome by engineered probiotics$683,273
R01 · FY2022 · AT · contact PI
Environmental hygiene strategies to decrease the burden of antibiotic-resistant organisms in Intensive Care Unit SINKs (ICU SINK)$480,674
R01 · FY2022 · HS
Impact of early-life perturbations on pediatric microbiome maturation$756,349
R01 · FY2021 · AI · contact PI
Tunable therapeutic modulation of the gut microbiome by engineered probiotics$691,776
R01 · FY2021 · AT · contact PI
Structural, mechanistic, & evolutionary characterization of tetracycline destructases$667,614
U01 · FY2021 · AI · contact PI
PHYLOGENOMIC, TRANSCRIPTOMIC, VIROMIC, AND IMMUNOPROTEOMIC DETERMINANTS OF NECROTIZING ENTEROCOLITIS$584,478
R01 · FY2021 · HD
Occupational Exposure and Health Risk from Dairy Microbiome and Resistome to Dairy Farm Workers$488,461
R01 · FY2021 · OH · contact PI
Environmental hygiene strategies to decrease the burden of antibiotic-resistant organisms in Intensive Care Unit SINKs (ICU SINK)$486,558
R01 · FY2021 · HS
Tunable therapeutic modulation of the gut microbiome by engineered probiotics$698,741
R01 · FY2020 · AT · contact PI
STRUCTURAL, MECHANISTIC, & EVOLUTIONARY CHARACTERIZATION OF TETRACYCLINE DESTRUCTASES$638,045
U01 · FY2020 · AI · contact PI
PHYLOGENOMIC, TRANSCRIPTOMIC, VIROMIC, AND IMMUNOPROTEOMIC DETERMINANTS OF NECROTIZING ENTEROCOLITIS$608,245
R01 · FY2020 · HD
Environmental hygiene strategies to decrease the burden of antibiotic-resistant organisms in Intensive Care Unit SINKs (ICU SINK)$499,999
R01 · FY2020 · HS
Occupational Exposure and Health Risk from Dairy Microbiome and Resistome to Dairy Farm Workers$488,461
R01 · FY2020 · OH · contact PI
Tunable therapeutic modulation of the gut microbiome by engineered probiotics$704,830
R01 · FY2019 · AT · contact PI
STRUCTURAL, MECHANISTIC, & EVOLUTIONARY CHARACTERIZATION OF TETRACYCLINE DESTRUCTASES$651,846
R01 · FY2019 · AI · contact PI
PHYLOGENOMIC, TRANSCRIPTOMIC, VIROMIC, AND IMMUNOPROTEOMIC DETERMINANTS OF NECROTIZING ENTEROCOLITIS$616,852
R01 · FY2019 · HD
Occupational Exposure and Health Risk from Dairy Microbiome and Resistome to Dairy Farm Workers$487,692
R01 · FY2019 · OH · contact PI
Tunable therapeutic modulation of the gut microbiome by engineered probiotics$705,449
R01 · FY2018 · AT · contact PI
STRUCTURAL, MECHANISTIC, & EVOLUTIONARY CHARACTERIZATION OF TETRACYCLINE DESTRUCTASES$662,693
R01 · FY2018 · AI · contact PI
PHYLOGENOMIC, TRANSCRIPTOMIC, VIROMIC, AND IMMUNOPROTEOMIC DETERMINANTS OF NECROTIZING ENTEROCOLITIS$625,282
R01 · FY2018 · HD
Occupational Exposure and Health Risk from Dairy Microbiome and Resistome to Dairy Farm Workers$499,260
R01 · FY2018 · OH · contact PI
STRUCTURAL, MECHANISTIC, & EVOLUTIONARY CHARACTERIZATION OF TETRACYCLINE DESTRUCTASES$673,167
R01 · FY2017 · AI
PHYLOGENOMIC, TRANSCRIPTOMIC, VIROMIC, AND IMMUNOPROTEOMIC DETERMINANTS OF NECROTIZING ENTEROCOLITIS$591,103
R01 · FY2017 · HD
STRUCTURAL, MECHANISTIC, & EVOLUTIONARY CHARACTERIZATION OF TETRACYCLINE DESTRUCTASES$685,916
R01 · FY2016 · AI
ESTABLISHMENT AND DYNAMICS OF ANTIBIOTIC RESISTANCE RESERVOIRS IN DEVELOPING INTE$304,000
R01 · FY2016 · GM · contact PI
ESTABLISHMENT AND DYNAMICS OF ANTIBIOTIC RESISTANCE RESERVOIRS IN DEVELOPING INTE$304,000
R01 · FY2015 · GM · contact PI
ESTABLISHMENT AND DYNAMICS OF ANTIBIOTIC RESISTANCE RESERVOIRS IN DEVELOPING INTE$304,000
R01 · FY2014 · GM · contact PI
ESTABLISHMENT AND DYNAMICS OF ANTIBIOTIC RESISTANCE RESERVOIRS IN DEVELOPING INTE$304,000
R01 · FY2013 · GM · contact PI
METAGENOMIC ENGINEERING OF PROBIOTIC BACTERIA TO IMPROVE INTESTINAL COLONIZATION$2,120,967
DP2 · FY2012 · DK · contact PI